Research Team
Glenn G. Mattson, Jr.
Vice President, Equity Research
gmattson@ladenburg.com
Mr. Mattson has over 15 years of institutional equity analyst experience focusing on all subsectors within the technology segment, most recently as Senior Equity Analyst, Technology at Sidoti and Co. LLC, where he was the number one- or two-ranked analyst by Bloomberg on all stocks which qualified for Bloomberg’s ranking system. Prior to Sidoti, Mr. Mattson spent 13 years on the buy‐side first as the technology analyst at First Investors, a $2.5 billion mutual fund company, and later as the cofounder of GTK Capital, a small‐cap technology focused hedge fund which returned 9% per year on average. Glenn holds a bachelor’s degree from Manhattan College and Series 7, 63, 65, 86, and 87 licenses.
Healthcare & Life Sciences
Jeffrey S. Cohen
Director of Research | Managing Director, Equity Research Healthcare & Medical Technologies
Destiny Hance
Associate Director of Research
Michael J. Higgins
Managing Director, Senior Biopharmaceuticals Equity Research
Matthew L. Kaplan
Managing Director, Healthcare Research
Ahu Demir, Ph.D
Managing Director,
Equity Research, Biotechnology
Aydin Huseynov, M.D., CFA
Managing Director, Biotechnology Equity Research
Yield-Oriented Equities
Mickey M. Schleien, CFA
Managing Director, Equity Research
Christopher Nolan, CFA
Executive Vice President, Equity Research
Energy, Power & Infrastructure
Paul Fremont
Managing Director
Telecom, Media & Technology
Jon R. Hickman
Managing Director, Equity Research
Glenn G. Mattson, Jr.
Vice President, Equity Research